Aston University
aston.ac.ukTotal trials
26
Active
9
Phase 3
2
Total enrollment
3,236
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| TheaLoz Duo Eyedrop | — | — | — | — | — | 1 |
Next readouts
- 2026-12-30
Top conditions
- Dry Eye4
- Dry Eye Syndromes4
- Meibomian Gland Dysfunction4
- Eye Diseases1
- Parkinson Disease1
- Age Related Macular Degeneration1
- Dry Eye Disease (DED)1
- Hypersensitivity1
Frequently asked questions about Aston University
- How many clinical trials does Aston University have on ClinicalTrials.gov?
- Aston University is listed as the lead sponsor on 26 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Aston University's trials are in Phase 3?
- 2 of Aston University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Aston University focus on?
- Aston University's most-studied conditions on ClinicalTrials.gov are Dry Eye, Dry Eye Syndromes, Meibomian Gland Dysfunction, Eye Diseases, Parkinson Disease.
- When are Aston University's next clinical trial readouts?
- Aston University has 1 upcoming primary-completion readout tracked here; the soonest is “Protecting the Eyes of Gamers With Lubricating Eyedrops”, expected around 2026-12-30.